BioWorld MedTech

March 20, 2013

Chinese med-tech firm seeks to win in China, then disrupt U.S. market

SHANGHAI – In China, local med-tech manufacturers have successfully pushed multinationals' products to the side at least in some product lines, due to strong government incentives, their low cost and improved quality. Read More

To go or not to go: study examines obesity and THA

Washington roundup: House hearing calls on FDA to finalize mobile guidance

DiaTech assay helps docs tailor cancer treatment

Deals roundup: DSM and SpineVision in license, supply agreement for Bionate II

Financings roundup: HPT prices public offering of 14M shares at $25.55

Report from Europe: InspireMD wins CE mark for Nitinol carotid EPS

Agreements/contracts: GSD establishes distribution partnerships for Thunderbolt

Product Briefs

People in the News

Keeping you up to date on recent developments in oncology

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...